Natural Products Targeting Key Molecular Hallmarks in Gastric Cancer: Focus on Apoptosis, Inflammation, and Chemoresistance
Open Access
- 29 January 2026
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (3) , 1347
Abstract
Natural products have emerged as promising multi-target agents for addressing the complex biology of gastric cancer, a malignancy characterized by marked molecular heterogeneity, late clinical presentation, and frequent resistance to systemic therapies. This narrative synthesis integrates primarily preclinical evidence, with emerging clinical data, on how naturally derived compounds modulate three central molecular processes that drive gastric tumor progression and therapeutic failure: evasion of programmed cell death, persistent tumor-promoting inflammation, and chemoresistance. Compounds such as curcumin, resveratrol, berberine, ginsenosides, quercetin, and epigallocatechin gallate restore apoptotic competence by shifting the balance between pro-survival and pro-death proteins, destabilizing mitochondrial membranes, promoting cytochrome c release, and activating caspase-dependent pathways. These agents also exert potent anti-inflammatory effects by inhibiting nuclear factor kappa B and signal transducer and activator of transcription signaling, suppressing pro-inflammatory cytokine production, reducing cyclooxygenase activity, and modulating the tumor microenvironment through changes in immune cell behavior. In parallel, multiple natural compounds function as chemo-sensitizers by inhibiting drug efflux transporters, reversing epithelial–mesenchymal transition, attenuating cancer stem cell-associated traits, and suppressing pro-survival signaling pathways that sustain resistance. Collectively, these mechanistic actions highlight the capacity of natural products to simultaneously target interconnected hallmarks of gastric cancer biology. Ongoing advances in formulation strategies may help overcome pharmacokinetic limitations; however, rigorous biomarker-guided studies and well-designed clinical trials remain essential to define the translational relevance of these compounds.Keywords
This publication has 181 references indexed in Scilit:
- The Efficiency of Plant Extracts in the Prevention of Gastric Cancer: A Systematic ReviewHealth Science Reports, 2025
- PI3K/AKT/mTOR Axis in Cancer: From Pathogenesis to TreatmentMedcomm, 2025
- Ginsenoside RG3 Synergizes With STING Agonist to Reverse Cisplatin Resistance in Gastric CancerFood Science & Nutrition, 2025
- Predictive biomarkers in gastric cancerJournal of Cancer Research and Clinical Oncology, 2022
- Quercetin inhibiting the PD‐1/PD‐L1 interaction for immune‐enhancing cancer chemopreventive agentPhytotherapy Research, 2021
- Curcumin effect on cancer cells' multidrug resistance: An updatePhytotherapy Research, 2020
- Betulinic acid triggers apoptosis and inhibits migration and invasion of gastric cancer cells by impairing EMT progressCell Biochemistry and Function, 2020
- The RAS‐PI3K‐AKT‐NF‐κB pathway transcriptionally regulates the expression of BCL2 family and IAP family genes and inhibits apoptosis in fibrous epulisJournal of Clinical Laboratory Analysis, 2019
- Curcumin suppresses gastric cancer by inhibiting gastrin‐mediated acid secretionFEBS Open Bio, 2017
- Betulinic acid decreases expression of bcl-2 and cyclin D1, inhibits proliferation, migration and induces apoptosis in cancer cellsNaunyn-Schmiedeberg's Archives of Pharmacology, 2006